Children and the risk of fractures caused by oral corticosteroids
Children and the risk of fractures caused by oral corticosteroids
Oral corticosteroids are known to increase the risk of fracture in adults, but their effects in children remain uncertain. The medical records of general practitioners in the United Kingdom (from the General Practice Research Database) were used to estimate the incidence rates of fracture of children ages 4-17 years taking oral corticosteroids (n = 37,562) and of control children taking nonsystemic corticosteroids (n = 345,748). Each child with a fracture (n = 22,846) was subsequently matched by age, sex, practice, and calendar time to one child without a fracture. The average duration of treatment was 6.4 days (median, 5 days). The risk of fracture was increased in children with a history of frequent use of oral corticosteroids; children who received four or more courses of oral corticosteroids had an adjusted odds ratio (OR) for fracture of 1.32 (95% CI, 1.03-1.69). Of the various fracture types, the risk of humerus fracture was doubled in children who received four or more courses of oral corticosteroids (adjusted OR, 2.17 [1.01-4.67]). Fracture risk was also increased among children using 30 mg prednisolone or more each day (adjusted OR for fracture, 1.24 [1.00-1.52]) and among those receiving four or more courses of oral corticosteroids (OR, 1.32 [1.03-1.69]). Children who stopped taking oral corticosteroids had a comparable risk of fracture to those in the control group. Our findings suggest that children who require more than four courses of oral corticosteroid as treatment for underlying disease are at increased risk of fracture. It is not entirely clear whether this relates directly to oral corticosteroid use or the underlying disease and its severity. Irrespective of these issues, this group of children is at increased risk of fracture.
osteoporosis, glucocorticoid, epidemiology, childhood
913-918
Van Staa, T. P.
c7951548-8377-4909-9dc2-eb29456f9da9
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
Leufkens, H. G.
41c0b704-2e6f-484c-ae49-b21f8cb6ad17
Bishop, N.
3d9fae1a-1a35-4a75-807e-f01cbc93012d
May 2003
Van Staa, T. P.
c7951548-8377-4909-9dc2-eb29456f9da9
Cooper, C.
e05f5612-b493-4273-9b71-9e0ce32bdad6
Leufkens, H. G.
41c0b704-2e6f-484c-ae49-b21f8cb6ad17
Bishop, N.
3d9fae1a-1a35-4a75-807e-f01cbc93012d
Van Staa, T. P., Cooper, C., Leufkens, H. G. and Bishop, N.
(2003)
Children and the risk of fractures caused by oral corticosteroids.
Journal of Bone and Mineral Research, 18 (5), .
(doi:10.1359/jbmr.2003.18.5.913).
Abstract
Oral corticosteroids are known to increase the risk of fracture in adults, but their effects in children remain uncertain. The medical records of general practitioners in the United Kingdom (from the General Practice Research Database) were used to estimate the incidence rates of fracture of children ages 4-17 years taking oral corticosteroids (n = 37,562) and of control children taking nonsystemic corticosteroids (n = 345,748). Each child with a fracture (n = 22,846) was subsequently matched by age, sex, practice, and calendar time to one child without a fracture. The average duration of treatment was 6.4 days (median, 5 days). The risk of fracture was increased in children with a history of frequent use of oral corticosteroids; children who received four or more courses of oral corticosteroids had an adjusted odds ratio (OR) for fracture of 1.32 (95% CI, 1.03-1.69). Of the various fracture types, the risk of humerus fracture was doubled in children who received four or more courses of oral corticosteroids (adjusted OR, 2.17 [1.01-4.67]). Fracture risk was also increased among children using 30 mg prednisolone or more each day (adjusted OR for fracture, 1.24 [1.00-1.52]) and among those receiving four or more courses of oral corticosteroids (OR, 1.32 [1.03-1.69]). Children who stopped taking oral corticosteroids had a comparable risk of fracture to those in the control group. Our findings suggest that children who require more than four courses of oral corticosteroid as treatment for underlying disease are at increased risk of fracture. It is not entirely clear whether this relates directly to oral corticosteroid use or the underlying disease and its severity. Irrespective of these issues, this group of children is at increased risk of fracture.
This record has no associated files available for download.
More information
Published date: May 2003
Keywords:
osteoporosis, glucocorticoid, epidemiology, childhood
Identifiers
Local EPrints ID: 26067
URI: http://eprints.soton.ac.uk/id/eprint/26067
ISSN: 0884-0431
PURE UUID: 35937d35-45df-44cd-b13d-7fef6a3d1958
Catalogue record
Date deposited: 21 Apr 2006
Last modified: 18 Mar 2024 02:44
Export record
Altmetrics
Contributors
Author:
T. P. Van Staa
Author:
H. G. Leufkens
Author:
N. Bishop
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics